Systematic Multi‐Level Analyses Decode the Arthritis‐Neurodegeneration Axis With In Vivo Validation
Open Access
- 5 August 2026
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 13 (60) , e76930
Abstract
Arthritis may influence neurodegenerative risk, but directionality and mediators remain unclear. This study integrates population survival analysis, Mendelian randomization, transcriptomic mapping, and mouse perturbation to map osteoarthritis (OA)/rheumatoid arthritis (RA) links with five neurodegenerative outcomes and prioritize mediators. In 310 162 European‐ancestry UK Biobank participants, Cox models associate OA with higher risks of Alzheimer's disease (AD; hazard ratio: 1.13, 95% confidence interval: 1.04–1.22), Parkinson's disease (PD; 1.10, 1.00–1.21), and disorders of autonomic nervous system (DANS; 1.36, 1.06–1.74), and RA with higher AD risk (1.37, 1.13–1.67) (all p < 0.05), but not incident PD. Mendelian randomization prioritizes a modest protective genetic effect of RA on PD (odds ratio: 0.93, 0.88–0.99; p = 0.015), without reverse causation. Transcriptome‐wide association and colocalization analyses identify shared RA–PD genes and prioritize Ring Finger Protein 40 ( RNF40 ). In a collagen‐induced arthritis (CIA) and 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) mouse model, CIA attenuates dopaminergic injury, whereas systemic Rnf40 knockdown alleviates arthritis but exacerbates Parkinsonian pathology. Endogenous RNF40 is induced in arthritic joints but remains stable in midbrain. These cross‐layer data define arthritis–neurodegeneration connections and nominate RNF40 as a context‐dependent joint–brain candidate linking inflammatory arthritis with dopaminergic vulnerability.Keywords
Funding Information
- National Natural Science Foundation of China (82272544)
- National Natural Science Foundation of China (81672218)
- Natural Science Foundation of Jiangsu Province (BK20251945)
This publication has 24 references indexed in Scilit:
- Unveiling Alzheimer’s disease (1901–2025): Historical insights, global burden, biological mechanisms, diagnostics, and therapeutic strategiesAgeing Research Reviews, 2025
- Pathophysiological mechanisms linking osteoarthritis and neurodegenerative disease riskOsteoarthritis and Cartilage, 2025
- A review on the epidemiology of rheumatoid arthritis: An update and trends from current literatureBest Practice & Research Clinical Rheumatology, 2025
- Bone–brain crosstalk in osteoarthritis: pathophysiology and interventionsTrends in Molecular Medicine, 2024
- Osteoarthritis year in review 2024: Epidemiology and therapyOsteoarthritis and Cartilage, 2024
- Research progress in Alzheimer's disease and bone-brain axisAgeing Research Reviews, 2024
- Rheumatoid Arthritis and Risk of Parkinson Disease in KoreaJAMA Neurology, 2023
- Understanding the involvement of innate immunity and the Nrf2-NLRP3 axis on mitochondrial health in Parkinson's diseaseAgeing Research Reviews, 2023
- Widening the Spectrum of Risk Factors, Comorbidities, and Prodromal Features of Parkinson DiseaseJAMA Neurology, 2022
- Immortal Time Bias in Observational StudiesJAMA, 2021